Ehab A M El-Shoura, Lobna A Abdelzaher, Nesreen I Mahmoud, Omar A Farghaly, Mostafa Sabry, Mary Girgis Shahataa, Esraa A Salem, Hebatallah M Saad, Omnya Elhussieny, Magy R Kozman, Ahmed M Atwa
{"title":"对 \"联合使用莱菔素和β-谷甾醇可减轻奥氮平诱导的大鼠代谢紊乱:FOXO、PI3K/AKT、JAK/STAT3 和 MAPK 信号通路的启示\" [Int. Immunopharmacol.","authors":"Ehab A M El-Shoura, Lobna A Abdelzaher, Nesreen I Mahmoud, Omar A Farghaly, Mostafa Sabry, Mary Girgis Shahataa, Esraa A Salem, Hebatallah M Saad, Omnya Elhussieny, Magy R Kozman, Ahmed M Atwa","doi":"10.1016/j.intimp.2024.113556","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":" ","pages":"113556"},"PeriodicalIF":4.8000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to \\\"Combined sulforaphane and β-sitosterol mitigate against olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways\\\" [Int. Immunopharmacol. 140 (2024) 112904].\",\"authors\":\"Ehab A M El-Shoura, Lobna A Abdelzaher, Nesreen I Mahmoud, Omar A Farghaly, Mostafa Sabry, Mary Girgis Shahataa, Esraa A Salem, Hebatallah M Saad, Omnya Elhussieny, Magy R Kozman, Ahmed M Atwa\",\"doi\":\"10.1016/j.intimp.2024.113556\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13859,\"journal\":{\"name\":\"International immunopharmacology\",\"volume\":\" \",\"pages\":\"113556\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2024-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International immunopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.intimp.2024.113556\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International immunopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.intimp.2024.113556","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Corrigendum to "Combined sulforaphane and β-sitosterol mitigate against olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways" [Int. Immunopharmacol. 140 (2024) 112904].
期刊介绍:
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.